相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。RUNX1 mutations are frequent in de novo AML with noncomplex karyotype and confer an unfavorable prognosis
Susanne Schnittger et al.
BLOOD (2011)
The role of multiparameter flow cytometry for disease monitoring in AML
Wolfgang Kern et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2010)
Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials
David Grimwade et al.
BLOOD (2010)
Acute Leukemias with ETV6/ABL1 (TEL/ABL) Fusion: Poor Prognosis and Prenatal Origin
Jan Zuna et al.
GENES CHROMOSOMES & CANCER (2010)
Successful treatment with low-dose imatinib mesylate of therapy-related myeloid neoplasm harboring TEL-PDGFRB in a patient with acute promyelocytic leukemia
N. Asou et al.
HAEMATOLOGICA (2010)
Screening for diverse PDGFRA or PDGFRB fusion genes is facilitated by generic quantitative reverse transcriptase polymerase chain reaction analysis
Philipp Erben et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Cytogenetics of Childhood Acute Myeloid Leukemia: United Kingdom Medical Research Council Treatment Trials AML 10 and 12
Christine J. Harrison et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Minimal residual disease levels assessed by NPM1 mutation-specific RQ-PCR provide important prognostic information in AML
Susanne Schnittger et al.
BLOOD (2009)
Age-Related Risk Profile and Chemotherapy Dose Response in Acute Myeloid Leukemia: A Study by the German Acute Myeloid Leukemia Cooperative Group
Thomas Buechner et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Prospective analysis of TEL gene Rearrangements in childhood acute lymphoblastic leukemia: A children's oncology group study
Jeffrey E. Rubnitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Prognostic relevance of FLT3-TKD mutations in AML:: the combination matters -: an analysis of 3082 patients
Ulrike Bacher et al.
BLOOD (2008)
Molecular cytogenetic findings in a four-way t(1;12;5;12)(p36;p13;q33;q24) underlying the ETV6-PDGFRB fusion gene in chronic myelomonocytic leukemia
Barbara Crescenzi et al.
CANCER GENETICS AND CYTOGENETICS (2007)
Characterization of three new imatinib-responsive fusion genes in chronic myeloproliferative disorders generated by disruption of the platelet-derived growth factor receptor β gene
Christoph Walz et al.
HAEMATOLOGICA (2007)
Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype
S Schnittger et al.
BLOOD (2005)
Somatic heterozygous mutations in ETV6 (TEL) and frequent absence of ETV6 protein in acute myeloid leukemia
SBV van Doorn-Khosrovani et al.
ONCOGENE (2005)
CyDAS: a cytogenetic data analysis system
B Hiller et al.
BIOINFORMATICS (2005)
Acute myelogenous leukemia with the t(3;12)(q26;p13) translocation: Case report and review of the literature
IA Voutsadakis et al.
AMERICAN JOURNAL OF HEMATOLOGY (2003)
Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia:: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease
S Schnittger et al.
BLOOD (2002)
Comparison of chromosome banding analysis, interphase- and hypermetaphase-FISH, qualitative and quantitative PCR for diagnosis and for follow-up in chronic myeloid leukemia: a study on 350 cases
C Schoch et al.
LEUKEMIA (2002)
Evidence for position effects as a variant ETV6-mediated leukemogenic mechanism in myeloid leukemias with a t(4;12)(q11-q12;p13) or t(5;12)(q31;p13)
J Cools et al.
BLOOD (2002)
t(7;12)(q36;p13) and t(7;12)(q32;p13) -: translocations involving ETV6 in children 18 months of age or younger with myeloid disorders
RM Slater et al.
LEUKEMIA (2001)
Identification of new translocations involving ETV6 in hematologic malignancies by fluorescence in situ hybridization and spectral karyotyping
MD Odero et al.
GENES CHROMOSOMES & CANCER (2001)
分享论文
